CIK 0001253689 · Non-accelerated filer<br>Smaller reporting company
CRESCENT BIOPHARMA, INC.
Sign in to watch- Ticker
- CBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- Phone
- 617-430-5595
- Business address
- 300 FIFTH AVENUE, WALTHAM, MA, 02451
- Former names
- GLYCOMIMETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $285,501
- in 7 filings, $286K under 10b5-1 plans
Net −$285,501. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Brumm Joshua T −$160K Chief Executive Officer sold 3% of stake
- McNeill Jonathan −$77K President and COO sold 3% of stake
- Pinkas Jan −$12K Chief Scientific Officer sold 3% of stake
- Im Ellie Eunkyung −$11K Chief Medical Officer sold 3% of stake
- Bispham Barbara Harlin −$11K See Remarks sold 3% of stake
Reading 48 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-05-17 | Koenig Scott Director | Grant or award · Stock Option (right to buy) | +21,000 | 21,000 | ||
| 2019-05-17 | PEARSON TIMOTHY R Director | Grant or award · Common Stock | +21,000 | 21,000 | ||
| 2019-05-17 | Goldberg Mark Alan Director | Grant or award · Stock Option (right to buy) | +21,000 | 21,000 | ||
| 2019-05-17 | Jackson Scott Thomas Director | Grant or award · Stock Option (right to buy) | +21,000 | 21,000 | ||
| 2019-01-17 | King Rachel K. President, CEO | Grant or award · Employee Stock Option (right to buy) | +265,000 | 265,000 | ||
| 2019-01-17 | Magnani John L. SVP of Research, CSO | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2019-01-17 | Thackray Helen M. SVP Clinical Development, CMO | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2019-01-17 | Hahn Brian M. SVP Finance, CFO | Grant or award · Employee Stock Option (right to buy) | +90,000 | 90,000 | ||
| 2018-11-27 | Jackson Scott Thomas Director | Grant or award · Stock Option (right to buy) | +22,000 | 22,000 | ||
| 2018-10-18 | Magnani John L. SVP of Research, CSO | Sale | −3,527 | $14.02 | $49K | 75,793 |
| 2018-10-17 | Magnani John L. SVP of Research, CSO | Sale | −7,273 | $14.00 | $102K | 79,320 |
| 2018-10-16 | Magnani John L. SVP of Research, CSO | Sale | −14,200 | $14.01 | $199K | 86,593 |
| 2018-06-11 | Hahn Brian M. CFO | Option exercise | +5,260 | $1.12 | $6K | 19,345 |
| 2018-06-11 | Hahn Brian M. CFO | Sale | −19,345 | $18.04 | $349K | 0 |
| 2018-06-11 | Hahn Brian M. CFO | Option exercise · Employee Stock Option (right to buy) | −5,260 | 5,260 | ||
| 2018-05-23 | Magnani John L. SVP of Research, CSO | Option exercise | +1,491 | $0.33 | $492 | 100,793 |
| 2018-05-23 | Magnani John L. SVP of Research, CSO | Option exercise · Warrant to Purchase Common Stock (right to buy) | −895 | 0 | ||
| 2018-05-23 | Magnani John L. SVP of Research, CSO | Option exercise · Warrant to Purchase Common Stock (right to buy) | −596 | 0 | ||
| 2018-05-18 | BARRETT M JAMES Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2018-05-18 | Goldberg Mark Alan Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 |
Page 12 of 16 · 305 trades